FIELD: pharmacy. SUBSTANCE: invention proposes a pharmaceutical composition stabilized by the basic agent and containing (E)-3,5-dihydroxy-7-(4', 4''-fluorophenyl-2'-cyclopropyl- -quinoline-3'-yl)-6-heptenoic acid or its salt or ester. An aqueous solution or dispersion has pH value from 7 to 8. The composition shows good stability for time being without visible changes even after prolonged storage. EFFECT: improved quality and effectiveness of the composition. 11 cl, 6 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITOR OF VESSEL INTERNAL MEMBRANE THICKENING | 1992 |
|
RU2114620C1 |
| ANTINEUTROPHILIC AGENT | 2004 |
|
RU2356555C2 |
| CRYSTALLINE FORM OF QUINOLIN COMPOUND AND METHOD OF OBTAINMENT OF COMPOUND IN GIVEN FORM | 2004 |
|
RU2370489C2 |
| COMBINATION CONTAINING A COMPOUND OF ANGIOTENSIN II-ANTAGONISTIC ACTIVITY | 1997 |
|
RU2188013C2 |
| T-TYPE CALCIUM CHANNEL-BLOCKING AGENT | 2004 |
|
RU2326886C2 |
| DERIVATIVES OF 3(2H)-PYRIDAZINONES OR THEIR PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND PHARMACEUTICAL COMPOSITION ON SAID | 1994 |
|
RU2138486C1 |
| PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2470637C2 |
| PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2121835C1 |
| DRUG USED IN CARDIAC FAILURE | 1994 |
|
RU2128043C1 |
| METHOD FOR PRODUCTION OF MEVALONELACTONE DERIVATIVES | 1989 |
|
RU2045529C1 |
